Setting a research agenda for progressive multiple sclerosis: The International Collaborative on Progressive MS

Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?

(2012) Jack Antel et al.   ACTA NEUROPATHOLOGICA

Experimental models of multiple sclerosis

(2011) Andrew R Pachner   CURRENT OPINION IN NEUROLOGY

Point-and-Click Cursor Control With an Intracortical Neural Interface System by Humans With Tetraplegia

(2011) Sung-Phil Kim et al.   IEEE TRANSACTIONS ON NEURAL SYSTEMS AND REHABILITATION ENGINEERING

Energy failure in multiple sclerosis and its investigation using MR techniques

(2011) David Paling et al.   JOURNAL OF NEUROLOGY

Towards molecular imaging of multiple sclerosis

(2011) David RJ Owen et al.   Multiple Sclerosis Journal

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

(2011) Stephen Sawcer et al.   NATURE

Nonprofit disease groups earmark grants for drug repositioning

(2011) Elie Dolgin   NATURE MEDICINE

Experimental in vivo and in vitro models of multiple sclerosis: EAE and beyond

(2011) Markus Kipp et al.   Multiple Sclerosis and Related Disorders

Evidence for Polygenic Susceptibility to Multiple Sclerosis—The Shape of Things to Come

(2010)   AMERICAN JOURNAL OF HUMAN GENETICS

An Unusual Cause of Multiple Cerebral Hemorrhages: Drotrecogin Alpha (Activated Protein C): Fig 1.

(2010) O. Algin et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab

(2010) Martin Gunnarsson et al.   ANNALS OF NEUROLOGY

Brain tissue sodium concentration in multiple sclerosis: a sodium imaging study at 3 tesla

(2010) M. Inglese et al.   BRAIN

CytoSolve: A Scalable Computational Method for Dynamic Integration of Multiple Molecular Pathway Models

(2010) V. A. Shiva Ayyadurai et al.   Cellular and Molecular Bioengineering

Quality of Life in Multiple Sclerosis: Determinants, Measurement, and Use in Clinical Practice

(2010) Deborah M. Miller et al.   Current Neurology and Neuroscience Reports

Chronic Progressive Multiple Sclerosis – Pathogenesis of Neurodegeneration and Therapeutic Strategies

(2010) Dirk Fitzner et al.   Current Neuropharmacology

Pharmacological management of symptoms in multiple sclerosis: current approaches and future directions

(2010) Alan J Thompson et al.   LANCET NEUROLOGY

Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial

(2010) Raju Kapoor et al.   LANCET NEUROLOGY

A novel adaptive design strategy increases the efficiency of clinical trials in secondary progressive multiple sclerosis

(2010) Jeremy Chataway et al.   Multiple Sclerosis Journal

Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: A meta-analytic approach

(2009) Maria Pia Sormani et al.   ANNALS OF NEUROLOGY

Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial

(2009) Andrew D Goodman et al.   LANCET

Predicting new molecular targets for known drugs

(2009) Michael J. Keiser et al.   NATURE

Imaging outcomes for neuroprotection and repair in multiple sclerosis trials

(2009) Frederik Barkhof et al.   Nature Reviews Neurology

Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS

(2009) F. Sellebjerg et al.   NEUROLOGY

Efficacy of paroxetine in treating major depressive disorder in persons with multiple sclerosis

(2008) Dawn M. Ehde et al.   GENERAL HOSPITAL PSYCHIATRY

Drug Target Identification Using Side-Effect Similarity

(2008) M. Campillos et al.   SCIENCE